Stock Information
Mirum Pharmaceuticals Inc (MIRM)
Ticker Symbol: MIRM
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $4,839.73 mil
Piotroski score: 6
PE Ratio: N/A
EPS (TTM): -0.4783
Revenue (TTM): $10.12 M
Dividend Yield: N/A%
ROE: -8.53%
Latest News
-
Mirum Pharmaceuticals to Announce First Quarter 2026 Financial Results and Host Conference Call on May 6, 2026
Wed, Apr 29, 2026 4:02 PM
-
Stifel Maintains Buy on Mirum Pharmaceuticals, Raises Price Target to $130
Wed, Apr 29, 2026 8:53 AM
-
SBIO: Leaning Into Drug Discovery And Medical Breakthroughs
Tue, Apr 28, 2026 10:41 AM
-
Baird Maintains Outperform on Mirum Pharmaceuticals, Raises Price Target to $112
Tue, Apr 28, 2026 7:19 AM
-
HC Wainwright & Co. Maintains Buy on Mirum Pharmaceuticals, Raises Price Target to $150
Mon, Apr 27, 2026 12:47 PM
-
Mirum Pharmaceuticals announces primary endpoint met in phase 2b portion of the Azure-1 study
Mon, Apr 27, 2026 8:46 AM
-
Mirum Pharma Announces Primary Endpoint Met In Phase 2b Portion Of AZURE-1 Study Evaluating Brelovitug For Treatment Of Chronic Hepatitis Delta Virus
Mon, Apr 27, 2026 8:10 AM
-
Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase 2b Portion of the AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Virus
Mon, Apr 27, 2026 8:03 AM
Key Financials
Financial data not available
